Leaderboard

Fr | De
Keine Artikel ausgewählt!     Warenkorb  
Sie sind hier: Fachliteratursuche » Leber » Leberzirrhose 23. März 2026
Suchen
Gastroplattform
Leberzirrhose
Erweiterte Suche
Abklärungen / Diagnostik
Therapien
Guidelines
Fortbildung
News / Journalscreening
Fachliteratursuche
Gallenwege
Leber
Hepatitis
Leberzirrhose
Neoplasie
Portale Hypertonie
Anderes
Magen-Darm
Oesophagus
Pankreas
Kongresse / Tagungen
Services / Tools
Links
Rect Top
  Schrift: Schrift grösser Schrift kleiner

   Seite 1 von 1910  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 38192  
   
Reassessing the Baveno based strategy in China: a cost-effectiveness analysis of screening for high-risk varices in cirrhosis.
Front Public Health
Su S, Luo J, Li C, Yang C, Yang J, Ding D, Liu X, Guo G, Han Y.
PMID: 41869588 [PubMed - indexed for MEDLINE]


Nanomedicine-Driven Modulation of Signaling Pathways in Hepatic Fibrosis.
Int J Nanomedicine
Ji P, Li Y, Jin Y, Dong Y, Li L, Ma Z, Liu L, Zhang Y, Ren Z.
PMID: 41869405 [PubMed - indexed for MEDLINE]


The Dual-Faceted Role of Metal-Based Nanomaterials in Hepatic Fibrosis Therapy.
Int J Nanomedicine
Mao Y, Gong Y, Bai X.
PMID: 41869402 [PubMed - indexed for MEDLINE]


Identification of potential biomarkers and therapeutic targets for liver cirrhosis based on Mendelian randomization and machine learning.
Biochem Biophys Rep
Zhang K, Chen T, Jia Z, Zhao J, Huang N.
PMID: 41869075 [PubMed]


Nomogram Using Taurocholic Acid, Age, and Albumin to Predict HBV-Related Cirrhosis/HCC in CHB Patients.
J Hepatocell Carcinoma
Zhang X, Zheng L, Zheng W, Shi J, Yu S, Liu H, Feng H, Yu Z.
PMID: 41868263 [PubMed]


HCC Is the Predominant Liver-Related Event in MASLD: 2-Step Non-Invasive Algorithms to Stratify Risk in Non-Cirrhotic Patients.
J Hepatocell Carcinoma
Indre MG, Stefanini B, Boe M, Capelli R, Chen R, Abbati C, Santangeli E, Salamone A, Girolami F, Tovoli F, Morelli MC, Piscaglia F, Ferri S, Ravaioli F.
PMID: 41868260 [PubMed]


Ammonia measurement in cirrhosis: International Delphi consensus recommendations from ISHEN.
J Hepatol
Ballester MP, Gallego-Durán R, Shalimar, Thomsen KL, Karvellas CJ, Dasarathy S, Shawcross DL, Thabut D, Chen J, Rose CF, Jalan R, Delphi panellists.
PMID: 41865800 [PubMed - as supplied by publisher]


Atorvastatin reduces recurrent decompensation events in advanced cirrhosis in a randomized placebo-controlled trial.
Sci Rep
Glal KAM, El-Haggar SM, Abdel-Salam SM, Mostafa TM.
PMID: 41865069 [PubMed - as supplied by publisher]


Association of nonselective β blockers with the development of hepatocellular carcinoma in liver cirrhosis: a meta-analysis.
Ann Hepatol
Xu Y, Wang X, Li X, Zhao Q, Xu X.
PMID: 41864541 [PubMed - as supplied by publisher]


Rheumatic Heart Disease Is Not Over: Cardiac Cirrhosis and Multivalvular Sequelae in an Endemic Setting - A Case Series and Review.
Curr Probl Cardiol
Sethi Y, Yadav ND, Singhal S, Singh AP, Singh A, Agarwal S, Sharma A, Pavlovic C, Pavlovic T, Mehta S.
PMID: 41864251 [PubMed - as supplied by publisher]


Analysis of 6-week mortality and influencing factors in patients with liver cirrhosis and portal vein thrombosis complicated by acute gastrointestinal bleeding.
PLoS One
Zhang J, Feng L.
PMID: 41860832 [PubMed - indexed for MEDLINE]


Focal lesions in the cirrhotic liver: an update on LI-RADS classification and clinical implications.
Dig Liver Dis
Blandino AA, Vernuccio F, Cannella R, Kilcoyne A, Tsai LL, Brancatelli G.
PMID: 41856903 [PubMed - as supplied by publisher]


Disentangling the Effect of BMI on Hepatocellular Carcinoma From Cirrhosis With Multivariable Mendelian Randomization.
Liver Int
Gkatzionis A, Sanderson E, Smith GD, Stender S, Gellert-Kristensen H.
PMID: 41853930 [PubMed - indexed for MEDLINE]


Continuous Versus Bolus Terlipressin for Acute Oesophageal Variceal Bleeding and Hepatorenal Syndrome in Cirrhosis: Meta-Analysis.
Liver Int
Hsieh PH, Yang TC, Kang EY, Chen YF, Lee PC, Lee KC, Huang HC, Luo JC, Hou MC.
PMID: 41853888 [PubMed - indexed for MEDLINE]


Care Pathways for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-The-Art Review.
Liver Int
van Eekhout KMA, Broekman LD, de Jong VD, Michel M, Grobbee R, Maya-Miles D, Romero-Gómez M, Muris J, Mendive JM, Vali Y, Franco OH, Schattenberg JM, Fournier-Poizat C, Castro Cabezas M, Tushuizen ME, Holleboom AG.
PMID: 41852336 [PubMed - indexed for MEDLINE]


Personalised Long-Term Albumin Treatment Based on Three-Month Ascites Response in Patients With Decompensated Cirrhosis.
Liver Int
Pompili E, Iannone G, Piano S, Toniutto P, Lombardo A, Gioia S, Tonon M, Gagliardi R, Carrello D, Tedesco G, Di Marco V, Zaccherini G, Lani L, Baldassarre M, Nardelli S, Bitetto D, Calvaruso V, Angeli P, Caraceni P.
PMID: 41851602 [PubMed - indexed for MEDLINE]


Optimising contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS) for hepatocellular carcinoma diagnosis in non-cirrhotic hepatitis B virus infection patients: incorporating alpha-fetoprotein or adjusting washout criteria.
Clin Radiol
Gong W, Gong S, Chang H, Ma C, Zhao Q, Zhou X, Zhou H.
PMID: 41849926 [PubMed - as supplied by publisher]


Clinical management of portal vein thrombosis in cirrhosis: an evidence‑based narrative review.
CVIR Endovasc
Dai K, Hansi N, See TC.
PMID: 41848981 [PubMed]


Liver Stiffness Measurement and All-Cause Mortality in Individuals With Diabetes.
JAMA Netw Open
Bril F, Huynh K, Bolla PR.
PMID: 41848734 [PubMed - indexed for MEDLINE]


Association of Early Heparin Use with Mortality in Cirrhotic Patients: A Retrospective Cohort Study.
Turk J Gastroenterol
Guo M, Ling T, Ding J, Shi X.
PMID: 41846528 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 38192    Seite 1 von 1910  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Ironmedline

Das Fachportal für Eisenmangel >>

 

Sky right 1